MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,712,862 | +181.5% | 126,758 | +243.1% | 0.10% | +196.9% |
| Q4 2022 | $1,674,205 | -61.6% | 36,950 | -40.8% | 0.03% | -72.2% |
| Q3 2022 | $4,360,000 | +20.2% | 62,433 | +41.6% | 0.12% | -28.1% |
| Q1 2022 | $3,626,000 | +52.9% | 44,098 | +200.4% | 0.16% | -44.3% |
| Q2 2021 | $2,371,000 | +677.4% | 14,679 | +724.7% | 0.29% | +537.8% |
| Q1 2021 | $305,000 | -82.1% | 1,780 | -77.1% | 0.04% | -83.8% |
| Q4 2020 | $1,706,000 | – | 7,766 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |